Publications by authors named "Sara Raiser"

Masters runners are often defined as those ages 35 years and older who train and compete in running events. These runners represent a growing population of the overall running community and experience running-related injuries including bone stress injuries (BSIs). Similar to younger runners, health considerations in masters runners include the goal to optimize bone health with focus on mitigating age-associated loss of bone strength and preventing BSIs through a combination of ensuring appropriate physical activity, optimizing nutrition, and correcting faulty biomechanics.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to evaluate how effective ultrasound imaging (USI) is compared to MRI for diagnosing bone stress injuries (BSI) in athletes.
  • Conducted with 37 patients suspected of having lower-extremity BSIs, the study found that USI had a sensitivity of 0.80 and specificity of 0.71 when compared to MRI results.
  • The findings suggest that USI could be a useful tool for sports medicine professionals, although more research is needed to explore its applications in patient follow-ups and return-to-play decisions.
View Article and Find Full Text PDF

Septic arthropathy leads to rapid joint destruction, impairment, and disability. Staphylococcus can be particularly virulent to bone and joints leading to adverse obstetric events. At 28 of weeks gestation, a patient presented with pyelonephritis and progressive left shoulder pain.

View Article and Find Full Text PDF

Advancing age and adiposity contribute to musculoskeletal degenerative diseases and the development of sarcopenic obesity. The etiology of muscle loss is multifactorial, and includes inflammation, oxidative stress and hormonal changes, and is worsened by activity avoidance due to fear of pain. The risk for mobility disability and functional impairment rises with severity of obesity in the older adult.

View Article and Find Full Text PDF

Vitamin D has been reported to lower blood pressure in vivo by regulating the renin-angiotensin system; however, there are limited clinical studies to support this finding in humans. We investigated the effect of vitamin D treatment on hypertension in a three-arm randomized placebo controlled pilot and feasibility study. We tested placebo with two forms of vitamin D: cholecalciferol (vitamin D(3)) and the active form of vitamin D, calcitriol.

View Article and Find Full Text PDF